2 Abbreviation key
A = Act NI = Notifiable instrument
AF = Approved form o = order
am = amended om = omitted/repealed
amdt = amendment ord = ordinance
AR = Assembly resolution orig = original
ch = chapter par = paragraph/subparagraph
CN = Commencement notice pres = present
def = definition prev = previous
DI = Disallowable instrument (prev...) = previously
dict = dictionary pt = part
disallowed = disallowed by the Legislative r = rule/subrule
Assembly reloc = relocated
div = division renum = renumbered
exp = expires/expired R[X] = Republication No
Gaz = gazette RI = reissue
hdg = heading s = section/subsection
IA = Interpretation Act 1967 sch = schedule
ins = inserted/added sdiv = subdivision
LA = Legislation Act 2001 SL = Subordinate law
LR = legislation register sub = substituted
LRA = Legislation (Republication) Act 1996 underlining = whole or part not commenced
mod = modified/modification or to be expired
Medicines, Poisons and Therapeutic Goods Regulation 2008
SL2008-42
notified LR 15 September 2008
s 1, s 2 commenced 15 September 2008 (LA s 75 (1))
remainder commenced 14 February 2009 (s 2 and see Medicines,
Poisons and Therapeutic Goods Act 2008 A2008-26, s 2 and LA s 79)
as amended by
2009 (No 1) SL2009-27
notified LR 5 June 2009
s 1, s 2 commenced 5 June 2009 (LA s 75 (1))
remainder commenced 6 June 2009 (s 2)
Statute Law Amendment Act 2009 (No 2) A2009-49 sch 3 pt 3.51
notified LR 26 November 2009
s 1, s 2 commenced 26 November 2009 (LA s 75 (1))
sch 3 pt 3.51 commenced 17 December 2009 (s 2)
2010 (No 1) SL2010-1
notified LR 21 January 2010
s 1, s 2 commenced 21 January 2010 (LA s 75 (1))
remainder commenced 22 January 2010 (s 2)
2010 (No 2) SL2010-2
notified LR 21 January 2010
s 1, s 2 commenced 21 January 2010 (LA s 75 (1))
remainder commenced 22 January 2010 (s 2)
Health Practitioner Regulation National Law (ACT) Act 2010 A2010-10
sch 2 pt 2.15
notified LR 31 March 2010
s 1, s 2 commenced 31 March 2010 (LA s 75 (1))
sch 2 pt 2.15 commenced 1 July 2010 (s 2 (1) (a))
2010 (No 3) SL2010-16
notified LR 10 May 2010
s 1, s 2 commenced 10 May 2010 (LA s 75 (1))
sch 1 commenced 1 July 2010 (s 2 (2) and see Health Practitioner
Regulation National Law (ACT) Act 2010 A2010-10 s 2 (1) (a))
remainder commenced 11 May 2010 (s 2 (1))
2010 (No 4) SL2010-20
notified LR 3 June 2010
s 1, s 2 commenced 3 June 2010 (LA s 75 (1))
remainder commenced 1 July 2010 (s 2 and see Health Practitioner
Regulation National Law (ACT) Act 2010 A2010-10 s 2 (1) (a))
Liquor (Consequential Amendments) Act 2010 A2010-43 sch 1 pt 1.14
notified LR 8 November 2010
s 1, s 2 commenced 8 November 2010 (LA s 75 (1))
sch 1 pt 1.14 commenced 1 December 2010 (s 2 (4) and see Liquor
Act 2010 A2010-35, s 2 (3) (as am by A2010-43 amdt 1.19) and
CN2010-14)
2010 (No 5) SL2010-45
notified LR 22 November 2010
s 1, s 2 commenced 22 November 2010 (LA s 75 (1))
remainder commenced 23 November 2010 (s 2)
Justice and Community Safety Legislation Amendment Act 2010
(No 4) A2010-50 sch 1 pt 1.6
notified LR 14 December 2010
s 1, s 2 commenced 14 December 2010 (LA s 75 (1))
sch 1 pt 1.6 commenced 21 December 2010 (s 2 (1))
Statute Law Amendment Act 2011 (No 3) A2011-52 sch 1 pt 1.5
notified LR 28 November 2011
s 1, s 2 commenced 28 November 2011 (LA s 75 (1))
sch 1 pt 1.5 commenced 12 December 2011 (s 2)
2012 (No 1) SL2012-5
notified LR 9 February 2012
s 1, s 2 commenced 9 February 2012 (LA s 75 (1))
remainder commenced 10 February 2012 (s 2)
Medicines, Poisons and Therapeutic Goods (Prescribing
Authorisation—Optometrists) Amendment Regulation 2012 (No 1)
SL2012-34
notified LR 2 August 2012
s 1, s 2 commenced 2 August 2012 (LA s 75 (1))
remainder commenced 3 August 2012 (s 2)
Medicines, Poisons and Therapeutic Goods (Kava Exemption)
Amendment Regulation 2013 (No 1) SL2013-1
notified LR 25 January 2013
s 1, s 2 commenced 25 January 2013 (LA s 75 (1))
remainder commenced 26 January 2013 (s 2)
2013 (No 1) SL2013-24
notified LR 29 August 2013
s 1, s 2 commenced 29 August 2013 (LA s 75 (1))
remainder commenced 1 September 2013 (s 2)
2013 (No 2) SL2013-28
notified LR 4 November 2013
s 1, s 2 commenced 4 November 2013 (LA s 75 (1))
remainder commenced 5 November 2013 (s 2)
Statute Law Amendment Act 2013 (No 2) A2013-44 sch 1 pt 1.3
notified LR 11 November 2013
s 1, s 2 commenced 11 November 2013 (LA s 75 (1))
sch 1 pt 1.3 commenced 25 November 2013 (s 2)
2014 (No 1) SL2014-23
notified LR 25 September 2014
s 1, s 2 commenced 25 September 2014 (LA s 75 (1))
s 11 commenced 1 October 2014 (s 2 (2))
remainder commenced 26 September 2014 (s 2 (1))
2014 (No 2) SL2014-26
notified LR 22 October 2014
s 1, s 2 commenced 22 October 2014 (LA s 75 (1))
remainder commenced 23 October 2014 (s 2)
2015 (No 1) SL2015-19
notified LR 21 May 2015
s 1, s 2 commenced 21 May 2015 (LA s 75 (1))
s 5 commenced 21 July 2015 (s 2 (2))
remainder commenced 22 May 2015 (s 2 (1))
Veterinary Surgeons Act 2015 A2015-29 sch 2 pt 2.10
notified LR 20 August 2015
s 1, s 2 commenced 20 August 2015 (LA s 75 (1))
sch 2 pt 2.10 commenced 1 December 2015 (s 2 (1) and CN2015-22)
Mental Health Act 2015 A2015-38 sch 2 pt 2.4 div 2.4.11
notified LR 7 October 2015
s 1, s 2 commenced 7 October 2015 (LA s 75 (1))
sch 2 pt 2.4 div 2.4.11 commenced 1 March 2016 (s 2 (1) and see
Mental Health (Treatment and Care) Amendment Act 2014 A2014-51,
s 2 (as am by A2015-38 amdt 2.54))
2015 (No 2) SL2015-36
notified LR 23 November 2015
s 1, s 2 commenced 23 November 2015 (LA s 75 (1))
remainder commenced 24 November 2015 (s 2)
Statute Law Amendment Act 2015 (No 2) A2015-50 sch 1 pt 1.3, sch 3
pt 3.24
notified LR 25 November 2015
s 1, s 2 commenced 25 November 2015 (LA s 75 (1))
sch 1 pt 1.3, sch 3 pt 3.24 commenced 9 December 2015 (s 2)
2016 (No 1) SL2016-5
notified LR 29 February 2016
s 1, s 2 commenced 29 February 2016 (LA s 75 (1))
remainder commenced 1 March 2016 (s 2)
Justice Legislation Amendment Act 2016 A2016-7 sch 1 pt 1.5
notified LR 29 February 2016
s 1, s 2 commenced 29 February 2016 (LA s 75 (1))
sch 1 pt 1.5 commenced 29 August 2016 (s 2 and LA s 79)
Medicines, Poisons and Therapeutic Goods (Controlled Medicines)
Amendment Regulation 2016 (No 1) SL2016-16
notified LR 30 June 2016
s 1, s 2 commenced 30 June 2016 (LA s 75 (1))
remainder commenced 31 July 2016 (s 2)
2017 (No 1) SL2017-27
notified LR 24 August 2017
s 1, s 2 commenced 24 August 2017 (LA s 75 (1))
remainder commenced 25 August 2017 (s 2)
Medicines, Poisons and Therapeutic Goods Amendment Act 2018
A2018-23 pt 3
notified LR 14 June 2018
s 1, s 2 commenced 14 June 2018 (LA s 75 (1))
pt 3 commenced 15 June 2018 (s 2)
Veterinary Practice Act 2018 A2018-32 sch 3 pt 3.12
notified LR 30 August 2018
s 1, s 2 commenced 30 August 2018 (LA s 75 (1))
sch 3 pt 3.12 commenced 21 December 2018 (s 2 and CN2018-12)
Statute Law Amendment Act 2018 A2018-42 sch 3 pt 3.24
notified LR 8 November 2018
s 1, s 2 taken to have commenced 1 July 2018 (LA s 75 (2))
sch 3 pt 3.24 commenced 22 November 2018 (s 2 (1))
Medicines, Poisons and Therapeutic Goods Regulation 2019 (No 1)
SL2019-23
notified LR 12 September 2019
s 1, s 2 commenced 12 September 2019 (LA s 75 (1))
remainder commenced 13 September 2019 (s 2)
Medicines, Poisons and Therapeutic Goods (Continued Dispensing)
Amendment Regulation 2020 (No 1) SL2020-3
notified LR 20 January 2020
s 1, s 2 commenced 20 January 2020 (LA s 75 (1))
remainder commenced 21 January 2020 (s 2)
2020 (No 1) SL2020-13
notified LR 3 April 2020
s 1, s 2 commenced 3 April 2020 (LA s 75 (1))
remainder commenced 4 April 2020 (s 2)
COVID-19 Emergency Response Act 2020 A2020-11 sch 1 pt 1.14
notified LR 7 April 2020
s 1, s 2 commenced 7 April 2020 (LA s 75 (1))
sch 1 pt 1.14 commenced 8 April 2020 (s 2 (1))
2020 (No 2) SL2020-21
notified LR 19 June 2020
s 1, s 2 commenced 19 June 2020 (LA s 75 (1))
remainder commenced 20 June 2020 (s 2)
2020 (No 3) SL2020-24
notified LR 26 June 2020
s 1, s 2 commenced 26 June 2020 (LA s 75 (1))
remainder commenced 27 June 2020 (s 2)
2020 (No 4) SL2020-31
notified LR 20 August 2020
s 1, s 2 commenced 20 August 2020 (LA s 75 (1))
remainder commenced 21 August 2020 (s 2)
2020 (No 5) SL2020-39
notified LR 9 September 2020
s 1, s 2 commenced 9 September 2020 (LA s 75 (1))
remainder commenced 10 September 2020 (s 2)
Statute Law Amendment Act 2021 A2021-12 sch 3 pt 3.36
notified LR 9 June 2021
s 1, s 2 commenced 9 June 2021 (LA s 75 (1))
sch 3 pt 3.36 commenced 23 June 2021 (s 2 (1))
2021 (No 1) SL2021-19
notified LR 17 August 2021
s 1, s 2 commenced 17 August 2021 (LA s 75 (1))
remainder commenced 18 August 2021 (s 2)
2021 (No 2) SL2021-28
notified LR 4 November 2021
s 1, s 2 commenced 4 November 2021 (LA s 75 (1))
remainder commenced 5 November 2021 (s 2)
2023 (No 1) SL2023-5
notified LR 6 April 2023
s 1, s 2 commenced 6 April 2023 (LA s 75 (1))
remainder commenced 7 April 2023 (s 2)
Health Infrastructure Enabling Act 2023 A2023-17 sch 2 pt 2.3
notified LR 2 June 2023
s 1, s 2 commenced 2 June 2023 (LA s 75 (1))
sch 2 pt 2.3 commenced 3 July 2023 (s 2 (2) and see s 7 (1) (a))
2023 (No 2) SL2023-17
notified LR 7 August 2023
s 1, s 2 commenced 7 August 2023 (LA s 75 (1))
remainder commenced 8 August 2023 (s 2)
2023 (No 3) SL2023-34
notified LR 11 December 2023
s 1, s 2 commenced 11 December (LA s 75 (1))
remainder commenced 12 December 2023 (s 2)
Health (Improved Abortion Access) Amendment Act 2024 A2024-30
s 10
notified LR 9 July 2024
s 1, s 2 commenced 9 July 2024 (LA s 75 (1))
s 10 commenced 10 July 2024 (s 2 (1))
2024 (No 1) SL2024-36
notified LR 12 December 2024
s 1, s 2 commenced 12 December 2024 (LA s 75 (1))
ss 6-8 commenced 12 June 2025 (s 2 (2))
remainder commenced 13 December 2024 (s 2 (1))
2025 (No 1) SL2025-7
notified LR 16 June 2025
s 1, s 2 commenced 16 June 2025 (LA s 75 (1))
remainder commenced 17 June 2025 (s 2)
Statute Law Amendment Act 2025 A2025-29 sch 4 pt 4.125
notified LR 6 November 2025
s 1, s 2 commenced 6 November 2025 (LA s 75 (1))
sch 4 pt 4.125 commenced 26 December 2025 (s 2 (7))
Health Legislation Amendment Act 2025 (No 2) A2025-33 pt 5
notified LR 12 November 2025
s 1, s 2 commenced 12 November 2025 (LA s 75 (1))
pt 5 commenced 26 November 2025 (s 2 (3))
Medicines, Poisons and Therapeutic Goods Amendment
Regulation 2025 (No 2) SL2025-29
notified LR 15 December 2025
s 1, s 2 commenced 15 December 2025 (LA s 75 (1))
remainder commenced 16 December 2025 (s 2)
Commencement
s 2 om LA s 89 (4)
s 3 am A2015-29 amdt 2.73
Overview of things to which medicines and poisons standard does not apply
s 6 am A2025-33 ss 12-16
General overview of authorisations for medicines
s 10 am A2010-10 amdt 2.85; A2025-33 s 17
Overview of medicines authorisations etc under this regulation
s 11 am SL2010-2 s 4; pars renum R4 LA; SL2013-28 s 4; pars
renum R17 LA; SL2014-23 s 11; SL2015-19 s 4; SL2016-5
s 4; pars renum R27 LA; SL2024-36 s 4; SL2025-7 s 4
sub SL2025-29 s 4
General overview of authorisation conditions for medicines
s 12 am SL2012-34 s 4; SL2025-29 s 5, s 6
Relationship with registration laws
pt 2.2 hdg sub A2010-10 amdt 2.86
Medicines authorisations subject to Health Practitioner Regulation National
Law (ACT) restrictions
s 20 sub A2010-10 amdt 2.86
am A2015-29 amdt 2.74
Medicines authorisations subject to Veterinary Practice Act 2018 restrictions
s 21 ins A2010-10 amdt 2.86
sub A2015-29 amdt 2.75; A2018-32 amdt 3.38
Authorisation under sch 1 to prescribe medicines—Act, s 40 (1) (b), (2) (b)
s 30 am SL2010-45 s 4; SL2019-23 s 4; SL2024-36 s 5; SL2025-29
s 7, s 8
Authorisation conditions for prescribing medicines—Act, s 44 (1) (b)
s 31 am SL2013-28 ss 5-7; pars renum R17 LA; SL2019-23 s 5;
SL2020-21 s 4; SL2021-28 s 4; SL2025-29 s 9
Variation of authorisation condition during Commonwealth special
arrangement period
s 31A ins SL2020-21 s 5
Additional requirements for prescribing controlled medicines for human use
s 32 am SL2025-29 s 10
Additional requirements for designated appendix D medicines prescriptions
s 33 om SL2019-23 s 6
Particulars for prescriptions
s 41 am SL2010-1 s 4; SL2010-45 s 5; pars renum R8 LA;
SL2013–28 s 8; ss renum R17 LA; SL2016-16 ss 4-6; pars
renum R28 LA; A2018-32 amdt 3.52; SL2019-23 ss 7-10;
pars renum R34 LA; SL2021-28 s 5; SL2024-36 s 6;
SL2025-29 s 11; pars renum R56 LA
Meaning of issuer—pt 3.2
s 49 ins SL2025-29 s 12
Authorisation conditions for issuing requisitions for medicines—Act, s 44 (1)
(b) and (2) (b)
s 51 am SL2025-29 s 13, s 14
General requirements for written requisitions
s 55 am SL2025-29 s 15
Particulars for requisitions
s 56 am SL2025-29 s 16
Authorisation conditions for issuing purchase orders for medicines—Act,
s 61 am SL2025-29 ss 17-20
Particulars for CHO standing orders for administration of medicines for
public health matters
s 72 am A2025-33 s 35
Particulars for standing orders for administration of medicines at institutions
s 76 am A2025-33 s 35
Standing orders for walk-in centre
div 3.4.3 hdg ins SL2010-2 s 5
Authorisation of CHO to issue standing orders for supply and administration
of medicines at walk-in centre—Act, s 42 (b)
s 77 ins SL2010-2 s 5
Particulars for CHO standing orders for supply and administration of
medicines at walk-in centre
s 78 ins SL2010-2 s 5
am A2025-33 s 35
Information for CHO about monitored medicines supplied on supply
authorities—Act, s 31 (1) (b) and (4), def required information
s 81 am SL2015-19 s 5
sub A2018-23 s 13
Overview of supply authorisations for medicines
s 100 am SL2013–28 s 9; pars renum R17 LA; SL2025-29 s 21
Authorisation under sch 1 to supply medicines—Act, s 26 (1) (b) and (2) (b)
s 110 am A2010-10 amdt 2.87; A2013-44 amdt 1.31
Authorisation conditions for dispensing medicines—Act, s 44 (1) (b)
s 120 am SL2013–28 s 10; SL2020-21 s 6; SL2025-29 s 22
Variation of authorisation condition for dispensing medicines during
Commonwealth special arrangement period
s 120A ins SL2020-21 s 7
How medicines are dispensed
s 121 am A2010-10 amdt 2.88, amdt 2.89; A2015-50 amdt 3.126;
SL2021-28 s 6; SL2024-36 s 7; ss renum R53 LA
Labelling dispensed medicines—Act, s 60 (1) (c) (i) and (2) (c) (i)
s 123 am SL2010-45 s 6; pars renum R8 LA; A2018-32 amdt 3.52;
A2025-33 s 35, s 36; SL2025-29 s 23; pars renum R56 LA
Marking dispensed prescriptions
s 124 am SL2013–28 s 11, s 12; SL2021-28 ss 7-9
Recording dispensing of medicines
s 125 am SL2024-36 s 8; A2025-33 s 35
Authorisation conditions for supplying medicines on requisitions—Act,
s 130 am SL2025-29 s 24
Labelling medicines supplied on requisition—Act, s 60 (1) (c) (i) and (2) (c) (i)
s 132 am A2025-33 s 35
Recording supply of medicines on requisitions
s 134 am SL2025-29 s 25, s 26
Authorisation conditions for supplying medicines on purchase orders—Act,
s 140 am SL2025-29 s 27
Supplying medicines on purchase orders
s 141 am A2025-33 s 35
Recording supply of medicines on purchase orders
s 142 am SL2025-29 s 28
Authorisation conditions for supplying medicines on standing orders—Act,
s 150 am SL2025-29 ss 29-31
Labelling medicines supplied on standing order—Act, s 60 (1) (c) (i)
s 152 am A2025-33 s 36
Authorisation conditions for supplying medicines during consultations—Act,
s 160 am SL2019-23 s 11; SL2025-29 s 32
Labelling medicines supplied during consultations
s 161 am SL2010-45 s 7; pars renum R8 LA; A2018-32 amdt 3.52;
A2025-33 s 35, s 36; SL2025-29 s 33; pars renum R56 LA
Recording medicines supplied during consultations
s 162 am A2025-33 s 35
Additional requirements for supplying controlled medicines for human use
during consultations
s 163 am SL2025-29 s 34, s 35
Information for CHO about monitored medicines supplied during
consultations—Act, s 31 (2) (b) and (4), def required information
s 164 sub A2018-23 s 14
Requirement to tell buyer about pseudoephedrine sales record
s 172 am A2021-12 amdt 3.87
Required information for pseudoephedrine sales records
s 173 am A2010-43 amdt 1.57; A2016-7 amdts 1.9-1.11; A2021-12
amdt 3.87
Authorisation conditions for supply of pharmacist only medicines—Act, s 44
(1) (b) and (2) (b)
s 180 am SL2025-29 s 36
Meaning of designated prescription only medicine—pt 4.3
s 250 am SL2019-23 s 12
Labelling medicines supplied without prescription in emergencies—Act,
s 253 am A2025-33 s 35, s 36
Authorisation to supply certain medicines without prescription—continued
pt 4.3A ins SL2013–28 s 13
Authorisation to supply certain medicines without prescription by approved
pharmacist––Act, s 185 (1) (g)
s 255 ins SL2013–28 s 13
am SL2020-3 s 4, s 5
Labelling certain medicines supplied without prescription by approved
pharmacist––Act, s 185 (1) (j)
s 256 ins SL2013–28 s 13
am A2025-33 s 35, s 36
Conditions for wholesalers supplying medicines under corresponding
laws—Act, s 20 (4) (c)
s 270 am SL2014-23 s 4, s 5
Authorisation conditions for administration of medicines at institutions by
people in health-related occupations—Act, s 44 (1) (b) and (2) (b)
s 351 am SL2025-29 s 37
Authorisation for pharmacist and intern pharmacist to administer vaccine
without prescription—Act, s 37 (1) (b)
s 352 ins SL2016-5 s 5
am SL2020-13 s 4; A2025-29 amdt 4.126
Authorisation for nurse or midwife to administer vaccine without
prescription—Act, s 37 (1) (b)
s 353 ins SL2020-31 s 4
Authorisation for self-administration etc of medicines—Act, s 37 (2) (b)
s 360 am SL2010-45 s 8; SL2025-29 s 38, s 39
Obtaining and possessing medicines
ch 6 hdg note ins SL2025-29 s 40
Discarding controlled medicines—Act, s 34 (1) (a)
s 390 am SL2025-29 s 41
Authorisations to deliver medicines under supply authorities—Act,
s 26 (1) (b), (2) (b), s 35 (1) (b), (2) (b) and s 36 (b)
s 400 am A2010-10 amdts 2.90-2.92; A2015-29 amdts 2.76-2.78
Emergency supply and administration of adrenaline, naloxone and
salbutamol
pt 9.2 hdg sub SL2024-36 s 9
Authorisations to supply and administer adrenaline, naloxone and
salbutamol—Act, s 26 (1) (b) and s 37 (1) (b)
s 410 hdg sub SL2024-36 s 10
s 410 am SL2024-36 s 11; SL2025-29 s 42
Authorisations for non-controlled medicines research and education—Act,
s 26 (1) and (2) (b)
s 430 am SL2021-28 s 10; A2025-33 s 18
Authorisation conditions for non-controlled medicines research and
education—Act, s 44 (1) (b) and (2) (b)
s 431 am A2025-33 s 18
Authorisations under controlled medicines research and education program
s 440 am A2025-33 s 18
Authorisation condition for controlled medicines research and education
program licences—Act, s 44 (1) (b) and (2) (b)
s 441 am A2025-33 s 18
Authorisation conditions for medicines wholesalers licences—Act,
s 461 am SL2014-23 s 6, s 7
Medicines authorisations for health practitioners
pt 9.6 hdg ins SL2015-19 s 6
sub SL2025-7 s 5
Authorisations for endorsed health practitioners—Act, s 20 (1) (d)
s 490 ins SL2015-19 s 6
sub SL2025-29 s 43
Authorisations for health practitioners to deal with medicines with CHO
approval—Act, s 20 (1) (c)
s 490A ins SL2025-7 s 6
Authorisations for dealing with COVID-19 vaccines
pt 9.7 hdg ins SL2021-19 s 4
Authorisation for dealing with COVID-19 vaccine during public health
emergency—Act, s 20 (1) (c)
s 491 ins SL2021-19 s 4
Expiry—pt 9.7
s 492 ins SL2021-19 s 4
When pharmacy medicines and pharmacist only medicines to be supplied in
manufacturer’s packs—Act, s 59 (1) (c) (i) and (2) (c) (i)
s 500 am A2010-10 amdt 2.93; A2015-29 amdts 2.79-2.81;
A2018-32 amdt 3.39
Packaging of supplied manufacturer’s packs of medicines—Act,
s 501 am A2015-50 amdt 1.10; A2025-33 s 19
Labelling of supplied manufacturer’s packs of medicines—Act, s 60 (1) (c) (i)
s 502 am A2015-50 amdt 1.11; A2025-33 s 20
Meaning of prescribed person—ch 11
s 510 am SL2010-16 s 4, s 5, amdt 1.1; SL2010-45 s 9; A2018-32
amdt 3.40, amdt 3.52; SL2020-39 s 4; SL2025-29 s 44
Storage of controlled medicines for certain health-related occupations—Act,
s 61 (b) and (c)
s 532 am SL2010-16 s 6, s 7, amdt 1.1; A2018-32 amdt 3.41, amdt
3.52; SL2020-39 s 5; SL2023-34 ss 4-8; SL2025-29 s 45,
s 46
Storage of controlled medicines by certain other prescribed people—Act,
s 61 (b) and (c)
s 533 am SL2010-16 s 8; A2018-32 amdt 3.52; SL2020-39 s 6;
SL2023-34 s 9; ss renum R50 LA; SL2025-29 s 47, s 48;
pars renum R56 LA
Storage of buprenorphine or methadone by opioid dependency treatment
licence-holders etc—Act, s 61 (b) and (c)
s 533A ins SL2023-34 s 10
Keeping of controlled medicines registers by certain people—Act, s 48 (a)
and s 50 (1) (b) and (2) (b)
s 540 table 540 am SL2010-16 s 9; A2018-32 amdt 3.42; SL2020-39
s 7; SL2025-29 s 49
Keeping of controlled medicines registers by first-aid kit holders—Act,
s 48 (a) and s 50 (1) (b) and (2) (b)
s 541 am SL2010-16 s 10, s 11, amdt 1.1; A2018-32 amdt 3.43;
A2018-32 amdt 3.52; SL2025-29 s 50, s 51
Prescribed witnesses for administration of controlled medicines—Act,
s 53 (a) and (b)
s 544 am SL2010-20 s 4; SL2020-39 s 8
sub SL2025-29 s 52
Prescribed witnesses for discarding of controlled medicines—Act, s 54 (a)
and (b)
s 545 am A2018-32 amdt 3.44, amdt 3.52; SL2020-39 s 9; pars
renum R41 LA; SL2025-29 ss 53-55
Meaning of designated prescriber—pt 13.1
s 551 am A2018-32 amdt 3.44; SL2025-29 s 56
Standing CHO approvals to prescribe controlled medicines in certain
circumstances—Act, s 20 (1) (c)
s 554 ins SL2025-29 s 57
Standing approval to prescribe controlled medicines for hospital in-patient
or patient discharge
s 555 sub SL2021-28 s 11
Standing approval to prescribe controlled medicines for short-term
treatment
s 556 sub SL2021-28 s 11
Controlled medicines to which standing approvals do not apply
s 556A ins SL2023-17 s 4
Standing interim approval to prescribe buprenorphine and methadone for
patients of certain institutions
s 557 hdg sub SL2010-1 s 5
s 557 am SL2010-1 s 6; pars renum R4 LA; SL2014-26 s 4;
SL2017-27 s 4, s 5
Application—div 13.1.3—standing CHO approvals to prescribe controlled
medicines in certain circumstances
s 559 ins SL2025-29 s 58
Applications for CHO controlled medicines approvals
s 560 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Requirements for CHO controlled medicines approval applications
s 561 am SL2016-16 s 7, s 8; ss and pars renum R28 LA;
SL2019-23 s 13; SL2021-28 s 12; SL2025-29 s 59
Restrictions on CHO power to approve applications for approvals
s 563 am SL2010-1 s 7; SL2014-26 s 5; SL2016-16 s 9; pars renum
R28 LA; SL2017-27 ss 6-10; ss renum R30 LA; SL2019-23
s 14, s 15; pars renum R34 LA
Term of CHO controlled medicines approvals
s 564 am SL2016-16 s 10; SL2025-29 s 60
Medicines advisory committee—referred applications and review of
unfavourable CHO decisions
s 566 am SL2014-26 s 6
Amendment and revocation of controlled medicines approvals
s 567 am SL2014-26 s 7
Application for review of amendment and revocation on CHO initiative
s 568 am SL2014-26 s 8
Medicines advisory committee—review of amendment or revocation on CHO
initiative
s 569 am SL2014-26 s 9
Conditional controlled medicines approvals
s 570 am SL2014-26 s 10
Form of CHO controlled medicines approvals
s 571 am SL2016-16 ss 11-13; ss and pars renum R28 LA;
SL2019-23 s 16; SL2025-29 s 61
Medicines advisory committee—recommendations to CHO
s 573 hdg sub SL2014-26 s 11
s 573 am SL2014-26 s 12, s 13
Guidelines for CHO decisions on applications
s 574 sub SL2014-26 s 14
Controlled medicines prescribing standards
s 575 ins SL2016-16 s 14
sub SL2019-23 s 17
am SL2025-29 s 62; A2025-29 amdt 4.126
Meaning of endorsement—div 13.1.4
s 580 am SL2017-27 s 11
Applications for CHO endorsement to treat drug-dependency
s 581 am SL2017-27 ss 12-15; A2021-12 amdt 3.87
CHO decisions on applications for endorsement to treat drug-dependency
s 582 am SL2017-27 s 16, s 17
Form of CHO endorsements to treat drug-dependency
s 583 am SL2017-27 s 18
Medicines advisory committee—review of CHO decisions to refuse
endorsements to treat drug-dependency
s 584 am SL2017-27 s 19
Appendix D medicines approvals
pt 13.2 hdg note am SL2019-23 s 18
Modification of medicines and poisons standard—Act, s 15 (1), def
medicines and poisons standard
s 588 ins SL2019-23 s 19
Meaning of ACT listed appendix D medicine
s 589 ins SL2019-23 s 19
Standing approval to prescribe ACT listed appendix D medicines
s 591 sub SL2019-23 s 20
Applications for CHO approval to prescribe appendix D medicines
s 592 hdg sub SL2019-23 s 21
s 592 am SL2019-23 ss 22-24; A2021-12 amdt 3.87
CHO decisions on applications to prescribe appendix D medicines
s 593 sub SL2019-23 s 25
Form of CHO appendix D medicines approvals
s 594 am SL2019-23 s 26
Applications for controlled medicines research and education program
s 605 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
First-aid kit licences
pt 14.3 hdg note am A2010-10 amdt 2.104; A2015-29 amdt 2.82
Applications for first-aid kit licences
s 610 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Additional information for first-aid kit licences—Act, s 88 (1) (k)
s 612 am A2009-49 amdt 3.121
Applications for medicines wholesalers licences
s 615 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Applications for opioid dependency treatment licences
s 620 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Applications for pharmacy medicines rural communities licences
s 625 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Opioid dependency treatment
pt 15.1 hdg sub SL2020-24 s 4
Guidelines for treatment of opioid dependency
s 630 am A2025-29 amdt 4.126
Minister may exempt certain people dealing with buprenorphine or
methadone from Act—Act, s 190 (1) (b)
s 631 ins SL2020-24 s 5
Certain people exempt from Act during COVID-19 emergency—Act,
s 190 (1) (a)
s 632 ins SL2020-24 s 5
exp 30 September 2022 (s 632 (3))
Medicines advisory committee—membership
s 635 am SL2014-26 ss 16-19; ss and pars renum R21 LA;
SL2021-28 s 13, s 14; SL2024-36 s 12, s 13; ss renum
R52 LA
Medicines advisory committee—conditions of appointments
s 637 am SL2021-28 s 15
Medicines advisory committee—quorum
s 640 am SL2014-26 s 20
Medicines advisory committee—disclosure of interests by members
s 643 am SL2014-26 s 21, s 22
Medicines advisory committee—ending appointments
s 644 am A2011-52 amdt 1.8; SL2014-26 s 23; pars renum R21 LA;
SL2021-28 s 15; SL2024-36 s 14; pars renum R52 LA
Advertising controlled medicines—Act, s 66 (3) (b)
s 650 am SL2014-23 s 8
Advertising other medicines
s 651 am A2018-32 amdt 3.46
Packaging of supplied manufacturer’s packs of low and moderate harm
poisons—Act, s 59 (1) (c) (i) and (2) (c) (i)
s 665 am A2015-50 amdt 1.12; A2025-33 s 21
Labelling of supplied manufacturer’s packs of low and moderate harm
poisons—Act, s 60 (1) (c) (i) and (2) (c) (i)
s 666 am A2015-50 amdt 1.13; A2025-33 s 22
General overview of authorisations for dangerous poisons
s 670 am A2025-33 s 23
Authorisation conditions for dangerous poisons manufacturers licences—
Act, s 44 (1) (b) and (2) (b)
s 676 am A2015-50 amdt 1.14; pars renum R26 LA
Authorisation conditions for dangerous poisons suppliers licences—Act,
s 686 am A2015-50 amdt 1.14; pars renum R26 LA; A2025-33 s 24
Manufacturing etc authorisations for dangerous poisons—Act, s 20 (2) (a)
s 690 am SL2024-36 s 15, s 16; pars renum R52 LA
Authorisations for dangerous poisons research and education—Act, s 26 (1)
s 695 am SL2021-28 s 16
Applications for dangerous poisons manufacturers licences
s 705 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Applications for dangerous poisons research and education program
s 710 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Applications for dangerous poisons suppliers licences
s 715 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Recording supply of dangerous poisons
s 722 sub A2015-50 amdt 1.15
am A2025-33 s 25
Packaging of supplied manufacturer’s packs of dangerous poisons—Act,
s 731 am A2015-50 amdt 1.16; A2025-33 s 26
Labelling of supplied manufacturer’s packs of dangerous poisons—Act,
s 732 am A2015-50 amdt 1.17; A2025-33 s 27
Storage of dangerous poisons—Act, s 61 (b) and (c)
s 735 am A2015-50 amdt 1.18; A2025-33 s 28
Manufacture, supply and use of first group paints for certain purposes—Act,
s 71 (1)
s 751 hdg sub A2025-33 s 29
s 751 am A2015-50 amdt 1.19, amdt 1.20; A2025-33 s 30, s 35
Manufacture, supply and use of paints or tinters for certain purposes—Act,
s 71 (3)
s 751A ins A2025-33 s 31
Manufacture, supply and use of paints for toys—Act, s 72 (b)
s 752 am SL2013–28 s 14, s 15
sub A2015-50 amdt 1.21; A2025-33 s 31
Manufacture, supply and use of paints containing pesticides—Act, s 73 (b)
s 753 sub A2015-50 amdt 1.22
am A2025-33 s 32
Prohibited and schedule 10 substances
ch 21 hdg am A2015-50 amdt 1.23
Meaning of prohibited substance—ch 21
s 760 am A2015-50 amdt 1.24, amdt 1.25
Applications for prohibited substances research and education program
s 765 am A2021-12 amdt 3.87; A2025-29 amdt 4.126
Meaning of reviewable decision—ch 23
s 850 am SL2009-27 s 4
Reviewable decision notices
s 851 sub SL2009-27 s 5
Applications for review
s 852 sub SL2009-27 s 5
Supply etc of certain declared substances by public employee exercising
functions under Act—Act, s 26 (1) (b) etc
s 860 hdg sub SL2023-5 s 4
Dealings with regulated substances and regulated therapeutic goods by
public employees under chief health officer permit—Act, s 20 (1) (a) etc
s 861 hdg sub SL2023-5 s 5
s 861 am SL2010-45 s 10
Dealings with regulated substances and regulated therapeutic goods by
public employees under director-general authorisation—Act, s 20 (1) (d)
and s 22 (1) (d)
s 861A ins SL2023-5 s 6
am A2023-17 amdt 2.9
Certain containers not to be used for human-use substances—Act,
s 63 (1) (b)
s 862 sub A2025-33 s 33
Displacement of Legislation Act, s 47 (6)
s 863 am SL2012-34 s 5, s 6
sub SL2013–28 s 16
am SL2014-23 s 9, s 10; pars renum R19 LA; SL2015-19 s 7;
pars renum R22 LA; A2015-50 amdt 1.26, amdt 1.27; pars
renum R26 LA; SL2020-39 s 10, s 11; SL2021-28 ss 17-19
Exemption of piper methysticum (kava)—Act, s 190 (1) (a)
s 864 om LA s 89 (3)
ins SL2012-5 s 4
exp 12 February 2012 (s 864 (3))
ins SL2013-1 s 4
Transitional
ch 30 hdg exp 31 March 2010 (s 1008)
Definitions—ch 30
s 1000 exp 31 March 2010 (s 1008)
def DODA exp 31 March 2010 (s 1008)
def PADA exp 31 March 2010 (s 1008)
DODA wholesaler’s licences—Act, s 520 (2)
s 1001 exp 31 March 2010 (s 1008)
Poisons Act licences—Act, s 520 (2)
s 1002 exp 31 March 2010 (s 1008)
PADA licences—Act, s 520 (2)
s 1003 exp 31 March 2010 (s 1008)
DODA authorisations—Act, s 522 (2)
s 1004 exp 31 March 2010 (s 1008)
PADA authorisations—Act, s 522 (2)
s 1005 exp 31 March 2010 (s 1008)
Public Health (Prohibited Drugs) Act authorisations—Act, s 522 (2)
s 1006 exp 31 March 2010 (s 1008)
DODA approvals to prescribe drugs of dependence—Act, s 531 (2)
s 1007 exp 31 March 2010 (s 1008)
Expiry—ch 30
s 1008 exp 31 March 2010 (s 1008)
Modification of Act
ch 31 hdg ins SL2009-27 s 6
Modification of Act, ch 14—Act, s 501 (2)
s 1100 ins SL2009-27 s 6
Expiry—ch 31
s 1110 ins SL2009-27 s 6
Ambulance services, officers and paramedics
sch 1 pt 1.1 hdg sub SL2025-29 s 63
sch 1 pt 1.1 am SL2025-29 ss 64-66
Dentists, dental hygienists, dental therapists and oral health therapists
sch 1 pt 1.2 hdg sub SL2015-36 s 4
sch 1 pt 1.2 am A2010-10 amdt 2.104; SL2015-36 s 5, s 6
Doctors
sch 1 pt 1.3 am A2010-10 amdt 2.104; SL2023-5 s 7; pars renum R46 LA
Health practitioners at institutions
sch 1 pt 1.4 hdg sub A2015-29 amdt 2.83
sch 1 pt 1.4 sub A2010-10 amdt 2.94
am A2015-29 amdt 2.84
Medical radiation practitioners
sch 1 pt 1.4A ins SL2020-39 s 12
am SL2025-29 s 67
Midwives
sch 1 pt 1.5 am A2010-10 amdt 2.104; SL2010-45 s 11; A2015-29
amdt 2.85; A2024-30 s 10; SL2025-29 s 68
Nurses
sch 1 pt 1.6 am SL2010-16 s 12; A2010-10 amdt 2.104; SL2010-20 s 5;
items renum R7 LA; A2018-42 amdt 3.74; SL2025-29 s 69,
s 70
Opioid dependency treatment centres operated by Territory
sch 1 pt 1.7 am A2010-10 amdt 2.104
Optometrists
sch 1 pt 1.8 am A2010-10 amdt 2.95; SL2012-34 s 7; SL2015-19 s 8
Residential care facilities
sch 1 pt 1.11 am A2010-10 amdt 2.104; SL2021-28 s 20
Veterinary practitioners and employees
sch 1 pt 1.13 sub A2018-32 amdt 3.47
Optometry medicines
sch 2 am A2010-10 amdt 2.96
om SL2012-34 s 8
ACT listed appendix D medicines—standing approvals
sch 3 hdg sub SL2019-23 s 27
sch 3 am SL2010-45 s 12; SL2013-24 s 4, s 5; SL2014-23 s 11;
A2015-38 amdt 2.80; SL2019-23 s 28, s 29; A2020-11
amdt 1.60; SL2021-28 ss 21-25
Health Professionals Regulation 2004
sch 6 om LA s 89 (3)
Modification—Crimes Act 1900
sch 10 ins SL2009-27 s 7
om A2010-50 amdt 1.14
dict am SL2009-27 s 8; A2009-49 amdt 3.122; A2010-10
amdt 2.97, amdt 2.98; SL2013–28 s 17; A2018-42
amdts 3.75-3.77; SL2019-23 s 30; SL2020-24 s 6;
SL2023-34 s 11; SL2024-36 s 17; SL2025-29 s 71
def ACT listed appendix D medicine ins SL2019-23 s 31
def appendix D medicine ins SL2019-23 s 31
def approved pharmacist ins SL2013–28 s 18
def Australian code of good wholesaling practice for
medicines in schedules 2, 3, 4 and 8 ins SL2014-23 s 12
def Australian code of good wholesaling practice for
therapeutic goods for human use om SL2014-23 s 13
def authorised midwife ins SL2010-45 s 13
def chief pharmacist reloc from Medicines, Poisons and
Therapeutic Goods Act 2008 dict by A2013-44 amdt 3.110
def complying purchase order am A2015-50 amdt 1.28
def condition 1 sub SL2019-23 s 32
def condition 2 sub SL2019-23 s 32
def condition 3 sub SL2019-23 s 32
def condition 4 sub SL2019-23 s 32
def continued dispensing determination ins SL2013–28
s 18
def controlled medicines prescribing standards ins
SL2019-23 s 33
def day hospital om A2018-42 amdt 3.78
def designated appendix D medicine ins SL2019-23 s 34
def drug-dependent person reloc from Medicines, Poisons
and Therapeutic Goods Act 2008 dict by A2013-44
amdt 3.112
def eligible midwife ins SL2010-45 s 13
om SL2025-29 s 72
def endorsed health practitioner ins SL2025-29 s 73
def enrolled nurse om SL2010-20 s 6
def enrolled nurse (medications) sub A2010-10 amdt 2.99
om SL2010-20 s 7
def health profession sub A2010-10 amdt 2.100
sub A2015-29 amdt 2.86
om A2018-42 amdt 3.79
def health professional om A2015-29 amdt 2.87
def intern sub A2010-10 amdt 2.101
def issuer ins SL2025-29 s 73
def manufacturer’s pack am A2025-33 s 35
def medical radiation practitioner ins SL2020-39 s 13
def medicines Australia code of conduct am SL2014-23
s 14
def MRP registration standard ins SL2020-39 s 13
def national list ins SL2012-34 s 9
om SL2015-19 s 9
def national residential medication chart prescription ins
SL2013–28 s 18
sub SL2021-28 s 26
def nurse practitioner ins SL2010-16 s 13
am SL2010-16 amdt 1.1
def Optometry endorsement scheduled medicines
registration standard ins SL2012-34 s 9; SL2014-23 s 15
om SL2015-19 s 9
def paramedic ins SL2025-29 s 73
def pharmaceutical benefit ins SL2013–28 s 18
def pharmaceutical benefits scheme ins SL2010-45 s 13
def prescriber sub SL2025-29 s 74
def primary pack om A2025-33 s 34
def prohibited substance am A2015-50 amdt 1.29
def scientifically qualified person sub A2018-32 amdt 3.49
def specialist sub A2010-10 amdt 2.102
def specialist area sub A2010-10 amdt 2.102; A2015-29
amdt 2.88; A2018-42 amdt 3.80
def trainee am A2010-10 amdt 2.103
sub A2015-29 amdt 2.89
def veterinary practitioner ins A2018-32 amdt 3.50
def veterinary surgeon om A2018-32 amdt 3.51
def walk-in centre ins SL2010-2 s 6
Some earlier republications were not numbered. The number in column 1 refers to
the publication order.
Since 12 September 2001 every authorised republication has been published in
electronic pdf format on the ACT legislation register. A selection of authorised
republications have also been published in printed format. These republications are
marked with an asterisk (*) in column 1. Electronic and printed versions of an
authorised republication are identical.
for
14 Feb 2009
14 Feb 2009–
not amended new regulation
6 June 2009–
16 Dec 2009
SL2009-27 amendments by
SL2009-27
17 Dec 2009
17 Dec 2009–
21 Jan 2010
A2009-49 amendments by
A2009-49
22 Jan 2010
22 Jan 2010–
31 Mar 2010
SL2010-2 amendments by
SL2010-1 and
SL2010-2
1 Apr 2010
1 Apr 2010–
A2010-10 commenced expiry
11 May 2010–
SL2010-16 amendments by
SL2010-16
1 July 2010–
22 Nov 2010
SL2010-20 amendments by
A2010-10,
SL2010-16 and
SL2010-20
23 Nov 2010
23 Nov 2010–
30 Nov 2010
SL2010-45 amendments by
SL2010-45
1 Dec 2010
1 Dec 2010–
20 Dec 2010
SL2010-45 amendments by
A2010-43
21 Dec 2010
21 Dec 2010–
11 Dec 2011
A2010-50 amendments by
A2010-50
12 Dec 2011
12 Dec 2011–
9 Feb 2012
A2011-52 amendments by
A2011-52
Earlier republications 5
for
10 Feb 2012
10 Feb 2012–
12 Feb 2012
SL2012-5 amendments by
SL2012-5
13 Feb 2012
13 Feb 2012–
2 Aug 2012
SL2012-5 expiry of provision
(s 864)
3 Aug 2013
3 Aug 2013–
25 Jan 2013
SL2012-34 amendments by
SL2012-34
26 Jan 2013
26 Jan 2013–
31 Aug 2013
SL2013-1 amendments by
SL2013-1
1 Sept 2013
1 Sept 2013–
4 Nov 2013
SL2013-24 amendments by
SL2013-24
5 Nov 2013
5 Nov 2013–
24 Nov 2013
SL2013-28 amendments by
SL2013-28
25 Nov 2013
25 Nov 2013–
25 Sept 2013
A2013-44 relocation of
provisions from
A2008-26 and
other amendments
by A2013-44
26 Sept 2014
26 Sept 2014–
30 Sept 2014
SL2014-23 amendments by
SL2014-23
1 Oct 2014
1 Oct 2014–
22 Oct 2014
SL2014-23 amendments by
SL2014-23
23 Oct 2014
23 Oct 2014–
SL2014-26 amendments by
SL2014-26
22 May 2015–
SL2015-19 amendments by
SL2015-19
21 July 2015–
23 Nov 2015
SL2015-19 amendments by
SL2015-19
24 Nov 2015
24 Nov 2015–
30 Nov 2015
SL2015-36 amendments by
SL2015-36
1 Dec 2015
1 Dec 2015–
8 Dec 2015
SL2015-36 amendments by
A2015-29
9 Dec 2015
9 Dec 2015–
29 Feb 2016
A2015-50 amendments by
A2015-50
for
1 Mar 2016
1 Mar 2016–
SL2016-5 amendments by
A2015-38
and SL2016-5
31 July 2016–
28 Aug 2016
SL2016-16 amendments by
SL2016-16
29 Aug 2016
29 Aug 2016–
24 Aug 2017
SL2016-16 amendments by
A2016-7
25 Aug 2017
25 Aug 2017–
SL2017-27 amendments by
SL2017-27
15 June 2018–
21 Nov 2018
A2018-23 amendments by
A2018-23
22 Nov 2018
22 Nov 2018–
20 Dec 2018
A2018-42 amendments by
A2018-42
21 Dec 2018
21 Dec 2018–
12 Sept 2019
A2018-42 amendments by
A2018-32
13 Sept 2019
13 Sept 2019–
20 Jan 2020
SL2019-23 amendments by
SL2019-23
21 Jan 2020
21 Jan 2020–
3 Apr 2020
SL2020-3 amendments by
SL2020-3
4 Apr 2020
4 Apr 2020–
7 Apr 2020
SL2020-13 amendments by
SL2020-13
8 Apr 2020
8 Apr 2020–
A2020-11 amendments by
A2020-11
20 June 2020–
SL2020-21 amendments by
SL2020-21
27 June 2020–
20 Aug 2020
SL2020-24 amendments by
SL2020-24
21 Aug 2020
21 Aug 2020–
9 Sept 2020
SL2020-31 amendments by
SL2020-31
10 Sept 2020
10 Sept 2020–
SL2020-39 amendments by
SL2020-39
23 June 2021–
17 Aug 2021
A2021-12 amendments by
A2021-12
Earlier republications 5
for
18 Aug 2021
18 Aug 2021–
4 Nov 2021
SL2021-19 amendments by
SL2021-19
5 Nov 2021
5 Nov 2021–
30 Sept 2022
SL2021-28 amendments by
SL2021-28
1 Oct 2022
1 Oct 2022–
6 Apr 2023
SL2021-28 expiry of provision
(s 632)
7 Apr 2023
7 Apr 2023–
SL2023-5 amendments by
SL2023-5
3 July 2023–
7 Aug 2023
A2023-17 amendments by
A2023-17
8 Aug 2023
8 Aug 2023–
29 Sept 2023
SL2023-17 amendments by
SL2023-17
30 Sept 2023
30 Sept 2023–
11 Dec 2023
SL2023-17 expiry of provisions
(pt 9.7)
12 Dec 2023
12 Dec 2023–
SL2023-34 amendments by
SL2023-34
10 July 2024–
12 Dec 2024
A2024-30 amendments by
A2024-30
13 Dec 2024
13 Dec 2024–
SL2024-36 amendments by
SL2024-36
12 June 2025–
SL2024-36 amendments by
SL2024-36
17 June 2025–
25 Nov 2025
SL2025-7 amendments by
SL2025-7
26 Nov 2025
26 Nov 2025–
15 Dec 2025
A2025-33 amendments by
A2025-33
16 Dec 2025
16 Dec 2025–
25 Dec 2025
SL2025-29 amendments by
SL2025-29